Professor Ashok Venkitaraman
Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.
Professor Douglas Fearon FRS FMedSci FRCP Basic Immunologist with a focus on Tumour Immunology
Doug is the Emeritus Sheila Joan Smith Professor of Immunology, University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Professor at Cold Spring Harbor Laboratory and at Weill Cornell Medicine, since 2014.
Eva Serrao – Radiology Academic Lecturer at the University of Cambridge, Addenbrookes Hospital
Eva Mendes Serrão, MD PhD received her medical degree from the University of Coimbra in Portugal in 2006 and then started her medical training in Clinical Radiology in Lisbon in 2008. During this period, her curiosity for science led her to volunteer in a basic research lab.
Dr. Ferdia Gallagher – Radiologist
Ferdia Gallagher is a Cancer Research UK Clinician Scientist Fellow at the CRUK Cambridge Research Institute and an Honorary Consultant Radiologist in the Department of Radiology in the University of Cambridge.
Florian Markowetz is a Royal Society Wolfson Research Merit Award holder and Senior Group Leader at the Cancer Research UK Cambridge Institute.
He holds degrees in Mathematics (Dipl. math.) and Philosophy (M.A.) from the University of Heidelberg and a Dr. rer. nat. (PhD equivalent) in Computational Biology from Free University Berlin, for which he was awarded an Otto-Hahn Medal by the Max Planck Society.
Professor Kevin Brindle
Kevin is Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a senior group leader in the Cancer Research UK Cambridge Institute. Since 2006 he has been working on metabolic imaging with hyperpolarized 13C-labelled cell substrates to detect treatment response in tumours.
Dr Martin L Miller MSc PhD
Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.